ES2061519T3 - Procedimiento para la produccion de acido eicosapentaenoico. - Google Patents

Procedimiento para la produccion de acido eicosapentaenoico.

Info

Publication number
ES2061519T3
ES2061519T3 ES87311372T ES87311372T ES2061519T3 ES 2061519 T3 ES2061519 T3 ES 2061519T3 ES 87311372 T ES87311372 T ES 87311372T ES 87311372 T ES87311372 T ES 87311372T ES 2061519 T3 ES2061519 T3 ES 2061519T3
Authority
ES
Spain
Prior art keywords
eicosapentaenoic acid
procedure
production
acid
optionally contains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87311372T
Other languages
English (en)
Inventor
Kazunaga Yazawa
Keiko Araki
Noriko Okazaki
Naganori Numao
Kiyosi Kondo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sagami Chemical Research Institute
Original Assignee
Sagami Chemical Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sagami Chemical Research Institute filed Critical Sagami Chemical Research Institute
Application granted granted Critical
Publication of ES2061519T3 publication Critical patent/ES2061519T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409—Fatty acids
    • C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
    • C12P7/6432—Eicosapentaenoic acids [EPA]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436—Fatty acid esters
    • C12P7/6445—Glycerides
    • C12P7/6472—Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/38—Pseudomonas

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

UN PROCEDIMIENTO PARA LA OBTENCION DE ACIDO EICOSAPENTAENOICO, QUE OPCIONALMENTE CONTIENE LIPIDOS, COMPRENDE LAS ETAPAS DE (A) CULTIVAR UN MICROORGANISMO CAPAZ DE PRODUCIR ACIDO EICOSAPENTAENOICO QUE CONTIENE LIPIDOS PERTENECIENTE AL GENERO PSEUDOMONAS, ALTEROMONAS Y SHEWANELLA, PARA OBTENER ACIDO EICOSAPENTAENOICO QUE CONTIENE LIPIDOS; Y (B) RECUPERAR EL ACIDO EICOSAPENTAENOICO, QUE OPCIONALMENTE CONTIENE LIPIDOS, DEL PRODUCTO CULTIVADO. TAMBIEN SE DESCRIBEN MICROORGANISMOS CAPACES DE PRODUCIR ACIDO EICOSAPENTAENOICO PERTENECIENTE AL GENERO PSEUDOMONAS, ALTEROMONAS Y SHEWANELLA.
ES87311372T 1986-12-26 1987-12-23 Procedimiento para la produccion de acido eicosapentaenoico. Expired - Lifetime ES2061519T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP30878486 1986-12-26
JP2051087 1987-02-02
JP2051187 1987-02-02
JP4993287 1987-03-06
JP7980687 1987-04-02

Publications (1)

Publication Number Publication Date
ES2061519T3 true ES2061519T3 (es) 1994-12-16

Family

ID=27520240

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87311372T Expired - Lifetime ES2061519T3 (es) 1986-12-26 1987-12-23 Procedimiento para la produccion de acido eicosapentaenoico.

Country Status (5)

Country Link
EP (1) EP0273708B1 (es)
AU (1) AU602376B2 (es)
CA (1) CA1321767C (es)
DE (1) DE3789435T2 (es)
ES (1) ES2061519T3 (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0324018A (ja) * 1989-06-22 1991-02-01 Tosoh Corp 脂質代謝改善剤
CH680448A5 (es) * 1990-01-17 1992-08-31 Nestle Sa
US5407957A (en) * 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
JP3354581B2 (ja) 1991-09-30 2002-12-09 サントリー株式会社 ジホモ−γ−リノレン酸及びこれを含有する脂質の製造方法
JPH0591886A (ja) * 1991-09-30 1993-04-16 Suntory Ltd ８，１１−エイコサジエン酸及びこれを含有する脂質の製造方法
EP4137128A1 (en) 2008-09-02 2023-02-22 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and a statin, and methods of using same
US8207363B2 (en) 2009-03-19 2012-06-26 Martek Biosciences Corporation Thraustochytrids, fatty acid compositions, and methods of making and uses thereof
NZ720946A (en) 2009-04-29 2017-09-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
MX350088B (es) 2009-04-29 2017-08-25 Amarin Pharma Inc Composicion farmaceutica estable y metodos de uso de la misma.
CN108096209A (zh) 2009-06-15 2018-06-01 阿马里纳制药公司 在相伴他汀类疗法的对象中降低甘油三酯、没有增加ldl-c水平的组合物和方法
US20110071176A1 (en) 2009-09-23 2011-03-24 Amarin Pharma, Inc. Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
BR122015020119B8 (pt) 2010-01-19 2021-05-04 Dsm Ip Assets Bv óleo microbiano, produtos alimentícios para um animal não humano e biomassa isolada
US11712429B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
NZ712068A (en) 2010-11-29 2017-03-31 Amarin Pharmaceuticals Ie Ltd Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
WO2013013211A1 (en) 2011-07-21 2013-01-24 Dsm Ip Assets B.V. Fatty acid compositions
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US20130131170A1 (en) 2011-11-07 2013-05-23 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
ES2891473T3 (es) 2012-01-06 2022-01-28 Amarin Pharmaceuticals Ie Ltd Composiciones y métodos para reducir los niveles de alta sensibilidad (hs-CRP) en un sujeto
CA3067012C (en) 2012-06-29 2021-10-05 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
WO2014074552A2 (en) 2012-11-06 2014-05-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
US9814733B2 (en) 2012-12-31 2017-11-14 A,arin Pharmaceuticals Ireland Limited Compositions comprising EPA and obeticholic acid and methods of use thereof
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US9662307B2 (en) 2013-02-19 2017-05-30 The Regents Of The University Of Colorado Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
US9283201B2 (en) 2013-03-14 2016-03-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for treating or preventing obesity in a subject in need thereof
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
US10172818B2 (en) 2014-06-16 2019-01-08 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
WO2018213663A1 (en) 2017-05-19 2018-11-22 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject having reduced kidney function
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
MA51766A (fr) 2018-09-24 2020-12-16 Amarin Pharmaceuticals Ie Ltd Procédés de réduction du risque d'événements cardiovasculaires chez un sujet
BR112022009189A2 (pt) 2019-11-12 2022-07-26 Amarin Pharmaceuticals Ie Ltd Métodos para reduzir o risco de eventos cardiovasculares em um sujeito com fibrilação atrial e/ou palpitação atrial
US11986452B2 (en) 2021-04-21 2024-05-21 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of heart failure

Also Published As

Publication number Publication date
EP0273708B1 (en) 1994-03-23
AU8300387A (en) 1988-06-30
CA1321767C (en) 1993-08-31
DE3789435T2 (de) 1994-10-20
AU602376B2 (en) 1990-10-11
EP0273708A3 (en) 1989-07-19
EP0273708A2 (en) 1988-07-06
DE3789435D1 (de) 1994-04-28

Similar Documents

Publication Publication Date Title
ES2052564T3 (es) Procedimiento para la produccion de acido bishomo-gamma-linolenico y acido eicosapanteonico.
ZA202207846B (en) Microorganism comprising variant lyse and method of l-amino acid production using same
ES2111052T3 (es) Procedimiento para la produccion de acido dihomo-gamma-linolenico y lipido que contiene el mismo.
UA32566C2 (uk) Спосіб одержання штаму мікроорганізму, спосіб продукування триптофану
JPS57105191A (en) Production of human urogastrone
DE68925002D1 (de) Verfahren zur Herstellung von optisch-aktiven alpha-substituierten organischen Säuren und Mikroorganismen und Enzyme, die dafür verwendet werden.
ES2089232T3 (es) 5-enolpiruvilsiquimato-3-fosfato sintasas tolerantes del glifosato.
BR9106038A (pt) Acido docasahexanoico,processos para sua producao e compostos contendo o mesmo
ATE332385T1 (de) Erfahren zur herstellung von hybridem saatgut mittels bedingter weiblicher sterilität
ES2188708T3 (es) Metodo de produccion de acido l-lactico con alta pureza optica utilizando cepas de bacillus.
DK0535939T3 (da) Fremgangsmåde til fremstilling af omega 9-type polyumættet fedtsyre
DE68915692D1 (de) Fermentationsverfahren zur Herstellung von 2-Keto-L-Gulonsäure.
WO1990012105A3 (en) Production of amino acids by methylotrophic bacillus
FI894001A0 (fi) Vaextgummimaterial och dess anvaendning i livsmedelsprodukter.
ES8308357A1 (es) Un procedimiento para la produccion de l-lisina.
ES8701734A1 (es) Un procedimiento para preparar hidantoinas opticamente acti-vas
ES474327A1 (es) Un procedimiento para producir el complejo antibiotico de desoxinarasina
DE69620363D1 (de) Prozess für die produktion von optisch aktiven 1-halo-3-amino-4-phenyl-2-butanol derivaten
ES2083449T3 (es) Copolimero de estireno y su produccion.
ES2062205T3 (es) Metodo para producir 2,2-dimetil-3-hidroxipropil-2,2-dimetil-3-hidroxipropionato.
MX9200910A (es) Procedimiento microbiologico para la preparacion de s-(+)-2,2- dimetilciclopropancarboxamida y acido r-(-)-2,2-dimetilciclopropancarboxilico.
ES2025027T3 (es) Procedimiento para la preparacion de eter-carboxilatos reforzantes de la detergencia.
ATE88497T1 (de) Verfahren zur herstellung von xylanase.
EP0355972A3 (en) Process for production of fatty acids having high degree of unsaturation
MX9300481A (es) Variedad mutante de maiz y metodo para su produccion.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 273708

Country of ref document: ES